Reinhard M. Berner
Expertise in
6
conditions

Reinhard M. Berner

Dresden, SN, DE 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
6
conditions
Dresden, SN, DE 

Overview

Reinhard Berner practices in Dresden, Germany. Mr. Berner is highly rated in 6 conditions, according to our data. His top areas of expertise are Streptococcal Group B Infection, Streptococcal Group A Infection, Severe Acute Respiratory Syndrome (SARS), and Strep Throat.

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Dresden, SN, Germany
Other Locations
Berlin, BE, Germany
Freiburg, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: February 10, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.
Enrollment Status: Recruiting
Publish Date: February 10, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3

163 Total Publications

Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023.
Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023.
Journal: Emerging microbes & infections
Published: November 03, 2025

Frequently Asked Questions about Reinhard M. Berner

Is Reinhard M. Berner a top-rated expert for Streptococcal Group B Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Reinhard M. Berner is classified as an Distinguished expert for Streptococcal Group B Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Reinhard M. Berner participate in research or clinical trials?

Yes. Reinhard M. Berner has published 163 articles and abstracts on conditions like Streptococcal Group B Infection. You can view a list of Reinhard M. Berner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berner's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile